MARKET INTRODUCTION
A renal disease can be attributed to various causes which, include injuries, genetics, and medicine. The renal disease occurs when the kidney cannot function properly. It is also known as kidney disease. There are different types of renal diseases and could be caused due to numerous dysfunctions and has different symptoms depending upon how the conditions affect the kidneys.
MARKET DYNAMICS
Factors such as increase in population suffering from kidney disease, the growing prevalence of diabetes and hypertension, and rapid growth in the geriatric population will spur the demand for renal disease market. Additionally, rising R&D and high healthcare expenditure and growing awareness regarding chronic disorders will boost the market growth to significant extent over the forecast period. However, rising healthcare cost and stringent regulatory policies impede the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Renal Disease Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of renal disease market with detailed market segmentation by disease type, treatment type, diagnosis, end-user and geography. The global renal disease market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading renal disease market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global renal disease market is segmented on disease type, treatment type, diagnosis, and end-user. Based on disease type, the global renal disease market is segmented into chronic kidney disease, end-stage renal disease (ESRD), acute kidney disease. Based on treatment type, the global renal disease market is segmented into dialysis, medication, kidney transplantation, surgery, diet, and others. Based on diagnosis, the global renal disease market is segmented into blood tests, imaging tests, biopsy, urine tests and others. Based on end users, the global renal disease market is segmented dialysis centers, hospital and clinics, and research and academic institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global renal disease market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The renal disease market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting renal disease market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Renal disease market in these regions.
MARKET PLAYERS
The reports cover key developments in the renal disease market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from renal disease market are anticipated to lucrative growth opportunities in the future with the rising demand for renal disease market in the global market. Below mentioned is the list of few companies engaged in the renal disease market.
The report also includes the profiles of key renal disease market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott
- Amgen Inc
- AstraZeneca
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Teva Pharmaceutical Industries Ltd
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Renal Disease Market - By Disease Type
1.3.2 Renal Disease Market - By Treatment Type
1.3.3 Renal Disease Market - By Diagnosis
1.3.4 Renal Disease Market - By End User
1.3.5 Renal Disease Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RENAL DISEASE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RENAL DISEASE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RENAL DISEASE MARKET - GLOBAL MARKET ANALYSIS
6.1. RENAL DISEASE - GLOBAL MARKET OVERVIEW
6.2. RENAL DISEASE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHRONIC KIDNEY DISEASE
7.3.1. Overview
7.3.2. Chronic Kidney Disease Market Forecast and Analysis
7.4. END-STAGE RENAL DISEASE (ESRD)
7.4.1. Overview
7.4.2. End-Stage Renal Disease (ESRD) Market Forecast and Analysis
7.5. ACUTE KIDNEY DISEASE
7.5.1. Overview
7.5.2. Acute Kidney Disease Market Forecast and Analysis
7.5.3. Prerenal Market
7.5.3.1. Overview
7.5.3.2. Prerenal Market Forecast and Analysis
7.5.4. Post renal Market
7.5.4.1. Overview
7.5.4.2. Post renal Market Forecast and Analysis
7.5.5. Renal Market
7.5.5.1. Overview
7.5.5.2. Renal Market Forecast and Analysis
8. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. DIALYSIS
8.3.1. Overview
8.3.2. Dialysis Market Forecast and Analysis
8.3.3. Hemodialysis Market
8.3.3.1. Overview
8.3.3.2. Hemodialysis Market Forecast and Analysis
8.3.4. Peritoneal Dialysis Market
8.3.4.1. Overview
8.3.4.2. Peritoneal Dialysis Market Forecast and Analysis
8.4. MEDICATION
8.4.1. Overview
8.4.2. Medication Market Forecast and Analysis
8.4.3. High Blood Pressure Medications Market
8.4.3.1. Overview
8.4.3.2. High Blood Pressure Medications Market Forecast and Analysis
8.4.4. Lower Cholesterol Levels Medications Market
8.4.4.1. Overview
8.4.4.2. Lower Cholesterol Levels Medications Market Forecast and Analysis
8.4.5. Medications to Treat Anemia Market
8.4.5.1. Overview
8.4.5.2. Medications to Treat Anemia Market Forecast and Analysis
8.4.6. Medications to Relieve Swelling Market
8.4.6.1. Overview
8.4.6.2. Medications to Relieve Swelling Market Forecast and Analysis
8.4.7. Medications to Protect Bones Market
8.4.7.1. Overview
8.4.7.2. Medications to Protect Bones Market Forecast and Analysis
8.5. KIDNEY TRANSPLANTATION
8.5.1. Overview
8.5.2. Kidney Transplantation Market Forecast and Analysis
8.5.3. Deceased-donor Kidney Transplant Market
8.5.3.1. Overview
8.5.3.2. Deceased-donor Kidney Transplant Market Forecast and Analysis
8.5.4. Living-donor Kidney Transplant Market
8.5.4.1. Overview
8.5.4.2. Living-donor Kidney Transplant Market Forecast and Analysis
8.5.5. Pre-emptive Kidney Transplant Market
8.5.5.1. Overview
8.5.5.2. Pre-emptive Kidney Transplant Market Forecast and Analysis
8.6. SURGERY
8.6.1. Overview
8.6.2. Surgery Market Forecast and Analysis
8.6.3. Nephrectomy and Radical Nephrectomy Market
8.6.3.1. Overview
8.6.3.2. Nephrectomy and Radical Nephrectomy Market Forecast and Analysis
8.6.4. Nephron-Sparing Surgery (NSS) Market
8.6.4.1. Overview
8.6.4.2. Nephron-Sparing Surgery (NSS) Market Forecast and Analysis
8.6.5. Nephrolithotripsy Market
8.6.5.1. Overview
8.6.5.2. Nephrolithotripsy Market Forecast and Analysis
8.6.6. Extracorporeal Shock Wave Lithotripsy (ESWL) Market
8.6.6.1. Overview
8.6.6.2. Extracorporeal Shock Wave Lithotripsy (ESWL) Market Forecast and Analysis
8.6.7. Others Market
8.6.7.1. Overview
8.6.7.2. Others Market Forecast and Analysis
8.7. DIET
8.7.1. Overview
8.7.2. Diet Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - DIAGNOSIS
9.1. OVERVIEW
9.2. DIAGNOSIS MARKET FORECASTS AND ANALYSIS
9.3. BLOOD TESTS
9.3.1. Overview
9.3.2. Blood tests Market Forecast and Analysis
9.3.3. Serum Creatinine Market
9.3.3.1. Overview
9.3.3.2. Serum Creatinine Market Forecast and Analysis
9.3.4. Glomerular Filtration Rate (GFR) Market
9.3.4.1. Overview
9.3.4.2. Glomerular Filtration Rate (GFR) Market Forecast and Analysis
9.3.5. Blood Urea Nitrogen (BUN) Market
9.3.5.1. Overview
9.3.5.2. Blood Urea Nitrogen (BUN) Market Forecast and Analysis
9.3.6. Fasting Blood Glucose Test Market
9.3.6.1. Overview
9.3.6.2. Fasting Blood Glucose Test Market Forecast and Analysis
9.4. IMAGING TESTS
9.4.1. Overview
9.4.2. Imaging Tests Market Forecast and Analysis
9.4.3. Ultrasound Market
9.4.3.1. Overview
9.4.3.2. Ultrasound Market Forecast and Analysis
9.4.4. CT Scan Market
9.4.4.1. Overview
9.4.4.2. CT Scan Market Forecast and Analysis
9.5. BIOPSY
9.5.1. Overview
9.5.2. Biopsy Market Forecast and Analysis
9.6. URINE TESTS
9.6.1. Overview
9.6.2. Urine tests Market Forecast and Analysis
9.6.3. Urinalysis Market
9.6.3.1. Overview
9.6.3.2. Urinalysis Market Forecast and Analysis
9.6.4. Protein Urine Test Market
9.6.4.1. Overview
9.6.4.2. Protein Urine Test Market Forecast and Analysis
9.6.5. Microalbuminuria Test Market
9.6.5.1. Overview
9.6.5.2. Microalbuminuria Test Market Forecast and Analysis
9.6.6. Creatinine Clearance Test Market
9.6.6.1. Overview
9.6.6.2. Creatinine Clearance Test Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis
10. RENAL DISEASE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. DIALYSIS CENTERS
10.3.1. Overview
10.3.2. Dialysis Centers Market Forecast and Analysis
10.4. HOSPITAL AND CLINICS
10.4.1. Overview
10.4.2. Hospital and Clinics Market Forecast and Analysis
10.5. RESEARCH AND ACADEMIC INSTITUTES
10.5.1. Overview
10.5.2. Research and Academic Institutes Market Forecast and Analysis
11. RENAL DISEASE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Renal Disease Market Overview
11.1.2 North America Renal Disease Market Forecasts and Analysis
11.1.3 North America Renal Disease Market Forecasts and Analysis - By Disease Type
11.1.4 North America Renal Disease Market Forecasts and Analysis - By Treatment Type
11.1.5 North America Renal Disease Market Forecasts and Analysis - By Diagnosis
11.1.6 North America Renal Disease Market Forecasts and Analysis - By End User
11.1.7 North America Renal Disease Market Forecasts and Analysis - By Countries
11.1.7.1 United States Renal Disease Market
11.1.7.1.1 United States Renal Disease Market by Disease Type
11.1.7.1.2 United States Renal Disease Market by Treatment Type
11.1.7.1.3 United States Renal Disease Market by Diagnosis
11.1.7.1.4 United States Renal Disease Market by End User
11.1.7.2 Canada Renal Disease Market
11.1.7.2.1 Canada Renal Disease Market by Disease Type
11.1.7.2.2 Canada Renal Disease Market by Treatment Type
11.1.7.2.3 Canada Renal Disease Market by Diagnosis
11.1.7.2.4 Canada Renal Disease Market by End User
11.1.7.3 Mexico Renal Disease Market
11.1.7.3.1 Mexico Renal Disease Market by Disease Type
11.1.7.3.2 Mexico Renal Disease Market by Treatment Type
11.1.7.3.3 Mexico Renal Disease Market by Diagnosis
11.1.7.3.4 Mexico Renal Disease Market by End User
11.2. EUROPE
11.2.1 Europe Renal Disease Market Overview
11.2.2 Europe Renal Disease Market Forecasts and Analysis
11.2.3 Europe Renal Disease Market Forecasts and Analysis - By Disease Type
11.2.4 Europe Renal Disease Market Forecasts and Analysis - By Treatment Type
11.2.5 Europe Renal Disease Market Forecasts and Analysis - By Diagnosis
11.2.6 Europe Renal Disease Market Forecasts and Analysis - By End User
11.2.7 Europe Renal Disease Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Renal Disease Market
11.2.7.1.1 Germany Renal Disease Market by Disease Type
11.2.7.1.2 Germany Renal Disease Market by Treatment Type
11.2.7.1.3 Germany Renal Disease Market by Diagnosis
11.2.7.1.4 Germany Renal Disease Market by End User
11.2.7.2 France Renal Disease Market
11.2.7.2.1 France Renal Disease Market by Disease Type
11.2.7.2.2 France Renal Disease Market by Treatment Type
11.2.7.2.3 France Renal Disease Market by Diagnosis
11.2.7.2.4 France Renal Disease Market by End User
11.2.7.3 Italy Renal Disease Market
11.2.7.3.1 Italy Renal Disease Market by Disease Type
11.2.7.3.2 Italy Renal Disease Market by Treatment Type
11.2.7.3.3 Italy Renal Disease Market by Diagnosis
11.2.7.3.4 Italy Renal Disease Market by End User
11.2.7.4 Spain Renal Disease Market
11.2.7.4.1 Spain Renal Disease Market by Disease Type
11.2.7.4.2 Spain Renal Disease Market by Treatment Type
11.2.7.4.3 Spain Renal Disease Market by Diagnosis
11.2.7.4.4 Spain Renal Disease Market by End User
11.2.7.5 United Kingdom Renal Disease Market
11.2.7.5.1 United Kingdom Renal Disease Market by Disease Type
11.2.7.5.2 United Kingdom Renal Disease Market by Treatment Type
11.2.7.5.3 United Kingdom Renal Disease Market by Diagnosis
11.2.7.5.4 United Kingdom Renal Disease Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Renal Disease Market Overview
11.3.2 Asia-Pacific Renal Disease Market Forecasts and Analysis
11.3.3 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Disease Type
11.3.4 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Treatment Type
11.3.5 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Diagnosis
11.3.6 Asia-Pacific Renal Disease Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Renal Disease Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Renal Disease Market
11.3.7.1.1 Australia Renal Disease Market by Disease Type
11.3.7.1.2 Australia Renal Disease Market by Treatment Type
11.3.7.1.3 Australia Renal Disease Market by Diagnosis
11.3.7.1.4 Australia Renal Disease Market by End User
11.3.7.2 China Renal Disease Market
11.3.7.2.1 China Renal Disease Market by Disease Type
11.3.7.2.2 China Renal Disease Market by Treatment Type
11.3.7.2.3 China Renal Disease Market by Diagnosis
11.3.7.2.4 China Renal Disease Market by End User
11.3.7.3 India Renal Disease Market
11.3.7.3.1 India Renal Disease Market by Disease Type
11.3.7.3.2 India Renal Disease Market by Treatment Type
11.3.7.3.3 India Renal Disease Market by Diagnosis
11.3.7.3.4 India Renal Disease Market by End User
11.3.7.4 Japan Renal Disease Market
11.3.7.4.1 Japan Renal Disease Market by Disease Type
11.3.7.4.2 Japan Renal Disease Market by Treatment Type
11.3.7.4.3 Japan Renal Disease Market by Diagnosis
11.3.7.4.4 Japan Renal Disease Market by End User
11.3.7.5 South Korea Renal Disease Market
11.3.7.5.1 South Korea Renal Disease Market by Disease Type
11.3.7.5.2 South Korea Renal Disease Market by Treatment Type
11.3.7.5.3 South Korea Renal Disease Market by Diagnosis
11.3.7.5.4 South Korea Renal Disease Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Renal Disease Market Overview
11.4.2 Middle East and Africa Renal Disease Market Forecasts and Analysis
11.4.3 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Disease Type
11.4.4 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Treatment Type
11.4.5 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Diagnosis
11.4.6 Middle East and Africa Renal Disease Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Renal Disease Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Renal Disease Market
11.4.7.1.1 South Africa Renal Disease Market by Disease Type
11.4.7.1.2 South Africa Renal Disease Market by Treatment Type
11.4.7.1.3 South Africa Renal Disease Market by Diagnosis
11.4.7.1.4 South Africa Renal Disease Market by End User
11.4.7.2 Saudi Arabia Renal Disease Market
11.4.7.2.1 Saudi Arabia Renal Disease Market by Disease Type
11.4.7.2.2 Saudi Arabia Renal Disease Market by Treatment Type
11.4.7.2.3 Saudi Arabia Renal Disease Market by Diagnosis
11.4.7.2.4 Saudi Arabia Renal Disease Market by End User
11.4.7.3 U.A.E Renal Disease Market
11.4.7.3.1 U.A.E Renal Disease Market by Disease Type
11.4.7.3.2 U.A.E Renal Disease Market by Treatment Type
11.4.7.3.3 U.A.E Renal Disease Market by Diagnosis
11.4.7.3.4 U.A.E Renal Disease Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Renal Disease Market Overview
11.5.2 South and Central America Renal Disease Market Forecasts and Analysis
11.5.3 South and Central America Renal Disease Market Forecasts and Analysis - By Disease Type
11.5.4 South and Central America Renal Disease Market Forecasts and Analysis - By Treatment Type
11.5.5 South and Central America Renal Disease Market Forecasts and Analysis - By Diagnosis
11.5.6 South and Central America Renal Disease Market Forecasts and Analysis - By End User
11.5.7 South and Central America Renal Disease Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Renal Disease Market
11.5.7.1.1 Brazil Renal Disease Market by Disease Type
11.5.7.1.2 Brazil Renal Disease Market by Treatment Type
11.5.7.1.3 Brazil Renal Disease Market by Diagnosis
11.5.7.1.4 Brazil Renal Disease Market by End User
11.5.7.2 Argentina Renal Disease Market
11.5.7.2.1 Argentina Renal Disease Market by Disease Type
11.5.7.2.2 Argentina Renal Disease Market by Treatment Type
11.5.7.2.3 Argentina Renal Disease Market by Diagnosis
11.5.7.2.4 Argentina Renal Disease Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RENAL DISEASE MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. RENAL DISEASE MARKET, KEY COMPANY PROFILES
14.1. ABBOTT
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. AMGEN INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ASTRAZENECA
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BRISTOL-MYERS SQUIBB COMPANY
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. F. HOFFMANN-LA ROCHE LTD
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. GLAXOSMITHKLINE PLC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. NOVARTIS AG
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. PFIZER INC.
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. SANOFI SA
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. TEVA PHARMACEUTICAL INDUSTRIES LTD
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott
2. Amgen Inc
3. AstraZeneca
4. Bristol-Myers Squibb Company
5. F. Hoffmann-La Roche Ltd
6. GlaxoSmithKline PLC
7. Novartis AG
8. Pfizer Inc.
9. Sanofi SA
10. Teva Pharmaceutical Industries Ltd
Global & China Electrodes for Medical Ma..
Summary
Publisher estimates that the Electrodes for Medical..
+1-646-791 7070US (Toll Free)